Moderna Inc. (MRNA) News
Filter MRNA News Items
MRNA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MRNA News Highlights
- MRNA's 30 day story count now stands at 23.
- Over the past 18 days, the trend for MRNA's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
- AMP, LI and GENE are the most mentioned tickers in articles about MRNA.
Latest MRNA News From Around the Web
Below are the latest news stories about MODERNA INC that investors may wish to consider to help them evaluate MRNA as an investment opportunity.
Tech Stalls As Rising Bond Yields Spook InvestorsIt's been an inauspicious start to the 2024 trading year, with all three major indexes in the red midday. |
The Biggest Losers in S&P 500 This Year: Dollar General, Moderna, and MoreThe five worst performers in the market benchmark so far this year could be set for brighter futures. |
Walgreens, Nike, Moderna: Bargain hunting stocksThe most recent bull market run has been widely described as "weird," with several household stocks underperforming during the bull run on S&P 500 (^GSPC) components. Yahoo Finance Reporter Madison Mills showcases three of these companies — Moderna (MRNA), Walgreens (WBA), and Nike (NKE) — where investors may find the most value for a bargain price on the stocks. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. |
S&P 500 Is Nearing a Record High. This Could Derail It in 2024.Microsoft and OpenAI are sued by the New York Times for copyright infringement, Amazon plans to launch adverts on Prime Video next month, and other news to start your day. |
The Winners and Losers: 2023 Stock Market Performance ReviewThe 2023 stock market saw steep declines followed by rapid upswings, but we're ending the year on a high note (even if some stocks aren't). |
Moderna and Pfizer Stock Tumbled in 2023. Wall Street Sees a Rebound.Covid-19-vaccine makers Moderna and Pfizer saw shares drop in 2023, but analysts expect double-digit-percentage gains next year. |
Why Is RayzeBio (RYZB) Stock Up 100% Today?RYZB stock has doubled today after Bristol Myers Squibb shelled out $4.1 billion to buy RayzeBio. |
Should You Buy This Year's Worst-Performing S&P 500 Stocks for 2024?Some of this year's underperformers could have brighter futures. |
20 Best Countries for Doctors to Immigrate toIn this article, we will list and explore the 20 best countries for doctors to immigrate to. You can skip our detailed analysis and go directly to our list of 5 Best Countries for Doctors to Immigrate to. For many medical professionals, the United States has historically been an attractive destination due to its renowned healthcare […] |
What to Know About the New Fast-Spreading Covid-19 StrainThe alert about the new variant, called JN.1, comes as hospitalizations of patients with Covid-19 are climbing in the U.S., amid a seasonal increase in respiratory virus hospitalizations. |